Skip to main content

Year: 2019

 Burlington Stores, Inc. Reports Third Quarter 2019 Earnings Above Guidance and Increases Full Year 2019 Adjusted EPS Outlook

On a GAAP basis, total sales rose 8.6%, net income increased 26%, EPS increased 29% to $1.44, and total inventory decreased 5%On a Non-GAAP basis, — Comparable store sales increased 2.7%, on top of last year’s 4.4% increase— Adjusted EPS rose 28% to $1.55, which excludes a $0.02 charge for management transition costs,  above guidance of $1.37-$1.41 — Comparable store inventory decreased 4%Increasing outlook for FY19 Adjusted EPS to $7.28-$7.33, up from $7.14-$7.22 BURLINGTON, N.J., Nov. 26, 2019 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel at everyday low prices, today announced its results for the third quarter ended November 2, 2019.Michael O’Sullivan, CEO, stated, “We are pleased with our third quarter results, driven by...

Continue reading

Correction: UPP Olaines OÜ consolidated unaudited financial results for Q3 and 9 months of 2019

Following is a correction to UPP Olaines OÜ consolidated unaudited financial results for Q3 and 9 months of 2019 published 12:36 on November 26th 2019. The company included wrong attachments to the financial results release. With this correction the company has included the correct attachments.Management commentary for the third quarter of 2019 (‘Q3 2019’)During Q3 2019 the company made 634,901 EUR in operating income and during the first 9 months of 2019 the operating income amounted to 1,879,700 EUR in total. Compared to Q3 2018 the operating income has increased by 6.3% and compared to first 9 months of 2018 the operating income has increased by 7.6%. The difference in operating income on quarterly basis is mainly due to adjustment made in Q3 2018 to correct mistakes of the previous quarters of 2018. 9 month results outperform comparative...

Continue reading

Correction: UPP Olaines OÜ 2019. aasta III kvartali ja 9 kuu konsolideeritud auditeerimata vahearuanne

Järgneb parandus ettevõtte 26. novembril kell 12:36 edastatud börsiteatele UPP Olaines OÜ 2019. aasta III kvartali ja 9 kuu konsolideeritud auditeerimata vahearuanne. Ettevõtte lisas valed aruanded avalikustatud börsiteatele. Käesoleva parandusega on börsiteatele lisatud õiged aruanded.2019. aasta kolmanda kvartali (‘III kv 2019’) tegevusaruanne2019. III kvartali jooksul oli ettevõtte ärikasum 634 901 eurot ning 2019. aasta esimese 9 kuu jooksul oli ärikasum kokku 1 879 700 eurot. Võrreldes 2018. III kvartaliga on ärikasum suurenenud 6,3% võrra ning võrreldes 2018. aasta esimese 9 kuuga on ärikasum kasvanud 7,6% võrra. Kvartali tasemel seletab kasvu  peamiselt III kv 2018 tehtud muudatus seoses eelnevate perioodide vea korrektsiooniga. 9 kuu tasemel seletab kasvu eelkõige üürihinna indekseerimine ning administratiivkulude langus.III kv...

Continue reading

ArcelorMittal S.A.: ArcelorMittal invests in new sustainability programme across Europe

ArcelorMittal invests in new sustainability programme across Europe  ArcelorMittal today announces plans to roll out a new sustainability programme across Europe, aiming to secure ResponsibleSteel site certification for all its ArcelorMittal Europe – Flat Products sites. The 12-month programme will enable each site to prove that our production processes meet rigorously defined standards across a broad range of social, environmental and governance criteria. ResponsibleSteel is the industry’s first global multi-stakeholder standard and certification initiative, dedicated to defining and promoting responsible practice, aimed at improving: The standard is based on 12 principles with a variety of criteria and underlying requirements. To be awarded with ResponsibleSteel certification, each site will undergo a rigorous third-party audit with...

Continue reading

OraSure Technologies to Present at the Piper Jaffray 31st Annual Healthcare Conference

BETHLEHEM, Pa., Nov. 26, 2019 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the Piper Jaffray 31st Annual Healthcare Conference. The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on Wednesday, December 4, 2019, at approximately 12:10 PM Eastern Time (9:10 AM Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investors link. A replay of the webcast will be available on OraSure Technologies’ web site for seven days. Alternatively, you can access the live webcast of the presentation via...

Continue reading

INmune Bio Inc. to Discuss Potential New Alzheimer’s Disease Treatments in CTAD Pre-Conference Webinar

INmune Bio’s CEO, Dr. R.J. Tesi, will moderate a panel of experts from neuroscience research, clinical trials, and Alzheimer’s drug development.LA JOLLA, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) — — INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing treatments that harness the patient’s innate immune system to fight disease, announced today its will host a live webinar on Tuesday, Dec. 3, 2019, from 1:00 p.m. to 2:00 p.m. (EST) titled, “Bench to Bedside: A Pre-CTAD Webinar Highlighting An Alternative Approach For Alzheimer’s Disease.” Attendees can register for the webinar by visiting https://russopartners.webex.com/russopartners/onstage/g.php?MTID=ea7cacd067c33e65bad04c76504eb28d2As host and moderator, INmune Bio’s Chief Executive Officer, R.J. Tesi, M.D., will be joined by the following experts in Alzheimer’s...

Continue reading

Kraken Reports Q3 2019 Results

ST. JOHN’S, Newfoundland, Nov. 26, 2019 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF), Canada’s Ocean Company, announced it has filed its financial results for the third quarter ended September 30, 2019. Additional information concerning the Company, including its unaudited condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the quarter ended September 30, 2019, can be found at www.sedar.com. Unless otherwise stated, all dollar amounts are Canadian dollar denominated.  Q3 2019 Financial HighlightsRevenue for the quarter of $7.8 million compared to $1.6 million in the year ago quarter. Year-to-date revenues were $10.5 million as compared to $5.2 million in the same period of 2018, representing growth of 102%.Majority of revenue in the quarter...

Continue reading

Itamar™ Medical Reports Record Third Quarter 2019 Revenues

– Third Quarter Revenues Increase 33% to $8.1 Million –– WatchPAT™ Revenues Increase 32% in the Third Quarter to $7.6 Million –– Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT –CAESAREA, Israel, Nov. 26, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today reported unaudited financial results for the three months and nine-month periods ended September 30, 2019.“Continued recognition of the value of our technology coupled with success in executing our strategies to penetrate the market in key geographies resulted in another quarter of record revenue,” said Gilad Glick, President and Chief Executive Officer of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.